Skip to content

Clinical trials

Completed Lymphoproliferative Disorders trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoproliferative Disorders Status: Completed Country / region: United Kingdom Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20102
20111
20151
20161
20171
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen Research (Munich) GmbH2
Amgen1
Cancer Research UK1
Celgene1
Nordic Nanovector1
University of Edinburgh1
University of Liverpool1
aTyr Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoproliferative Disorders9
Immunoproliferative Disorders4
Lymphatic Diseases4
Lymphoma4
Precursor Cell Lymphoblastic Leukemia-Lymphoma3
Burkitt Lymphoma2
Hodgkin Disease2
Immune System Diseases2
Leukemia2
Lymphoma, Large B-Cell, Diffuse2

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.